Addex Therapeutics Ltd ADR (ADXN)

$9.60 -0.25 (-2.54%)
Market Cap 10.44M
Revenue (ttm) 460,000.00
Net Income (ttm) 8.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,741.30%
Debt to Equity Ratio 0.00
Volume 8,900
Avg Vol 35,564
Day's Range N/A - N/A
Shares Out 1.06M
Stochastic %K 31%
Beta 1.38
Analysts Strong Buy
Price Target $30.00

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate re...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 22 884 1555
Fax: 41 22 884 1556
Address:
Chemin des Mines, 9, Geneva, Switzerland
NinjaaRai
NinjaaRai Oct. 24 at 8:18 PM
$ADXN $FUSE $QLGN $WGRX
0 · Reply
SpartanVI
SpartanVI Oct. 24 at 8:16 PM
$ADXN $FUSE $QLGN $WGRX Fuse looks ready for ah
0 · Reply
SpartanVI
SpartanVI Oct. 24 at 7:26 PM
$ADXN $FUSE $QLGN $WGRX Fuse Oversold here Potential reversal
0 · Reply
Eliza1
Eliza1 Oct. 24 at 5:00 PM
$ADXN can we just fill the $35 gap already?Another huge one at around $75-$80 when the market was much lower.
0 · Reply
Aaronwasinger
Aaronwasinger Oct. 24 at 8:32 AM
$ADXN $FUSE $QLGN $WGRX
0 · Reply
SpartanVI
SpartanVI Oct. 24 at 8:31 AM
$FUSE '' Charles Cassel hedge manager : predicts 200mil valuation potential // next Q revenue to reveal after it gets uplisted *makes the most sense* // '' $QLGN $ADXN $WGRX
0 · Reply
Manor007
Manor007 Oct. 23 at 8:19 PM
$ADXN load...load...on fire
0 · Reply
Manor007
Manor007 Oct. 23 at 8:11 PM
$ADXN mark my word....
0 · Reply
Manor007
Manor007 Oct. 23 at 8:01 PM
$ADXN going up
1 · Reply
CarlosRivera_
CarlosRivera_ Oct. 21 at 6:49 PM
Took a step back and waited for the right setup. The last one $ADXN hit 15.9 from the alert, can’t say I’m surprised. Got something new on the radar watching it close⚜️
0 · Reply
Latest News on ADXN
Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Transcript

Oct 1, 2025, 1:52 PM EDT - 23 days ago

Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Transcript

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 30, 2025, 1:00 AM EDT - 25 days ago

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

Sep 26, 2025, 1:00 AM EDT - 4 weeks ago

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

Addex Appoints Bank of New York Mellon as Depositary Bank

Sep 23, 2025, 1:00 AM EDT - 4 weeks ago

Addex Appoints Bank of New York Mellon as Depositary Bank

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs

Jun 30, 2025, 1:00 AM EDT - 4 months ago

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Jun 30, 2025, 1:00 AM EDT - 4 months ago

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Addex Shareholders Approve All Resolutions at Annual General Meeting

Jun 25, 2025, 1:00 AM EDT - 4 months ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Jun 19, 2025, 1:00 AM EDT - 4 months ago

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Jun 18, 2025, 1:00 AM EDT - 4 months ago

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Jun 6, 2025, 1:00 AM EDT - 5 months ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Addex Convenes Annual General Meeting 2025

Jun 3, 2025, 1:00 AM EDT - 5 months ago

Addex Convenes Annual General Meeting 2025

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

May 12, 2025, 1:00 AM EDT - 5 months ago

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Apr 30, 2025, 1:00 AM EDT - 6 months ago

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Apr 25, 2025, 4:40 PM EDT - 6 months ago

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Apr 25, 2025, 1:00 AM EDT - 6 months ago

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Apr 17, 2025, 1:00 AM EDT - 6 months ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Addex to Present at the 2025 Swiss Equities Baader Conference

Jan 8, 2025, 1:00 AM EST - 10 months ago

Addex to Present at the 2025 Swiss Equities Baader Conference

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Nov 22, 2024, 11:11 AM EST - 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 22, 2024, 1:00 AM EST - 1 year ago

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Nov 11, 2024, 1:00 AM EST - 1 year ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Sep 30, 2024, 12:04 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 30, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Sep 19, 2024, 1:00 AM EDT - 1 year ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 1:00 AM EDT - 1 year ago

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Aug 27, 2024, 12:03 PM EDT - 1 year ago

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 10:47 AM EDT - 1 year ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Aug 27, 2024, 1:00 AM EDT - 1 year ago

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Addex's Partner Discontinues ADX71149 development in Epilepsy

Jul 22, 2024, 1:00 AM EDT - 1 year ago

Addex's Partner Discontinues ADX71149 development in Epilepsy

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Jul 15, 2024, 1:00 AM EDT - 1 year ago

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Jul 12, 2024, 1:00 AM EDT - 1 year ago

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Jun 6, 2024, 12:50 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Jun 6, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Addex Convenes Annual General Meeting 2024

Jun 5, 2024, 1:00 AM EDT - 1 year ago

Addex Convenes Annual General Meeting 2024

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

May 31, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Addex to Present at Bio€quity Europe 2024

May 8, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at Bio€quity Europe 2024

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 29, 2024, 1:00 AM EDT - 1 year ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Addex to Present at the Swiss Biotech Day 2024

Apr 19, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at the Swiss Biotech Day 2024

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Apr 18, 2024, 1:46 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Apr 18, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Apr 11, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Apr 3, 2024, 1:00 AM EDT - 1 year ago

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Addex to Present at the Bio-Europe Spring 2024 Conference

Mar 14, 2024, 2:00 AM EDT - 1 year ago

Addex to Present at the Bio-Europe Spring 2024 Conference

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Jan 31, 2024, 1:00 AM EST - 1 year ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Addex to Present at the Swiss Equities Baader Conference

Jan 9, 2024, 1:00 AM EST - 1 year ago

Addex to Present at the Swiss Equities Baader Conference

Addex to Present at Biotech Showcase™ 2024

Jan 5, 2024, 1:30 AM EST - 1 year ago

Addex to Present at Biotech Showcase™ 2024

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Dec 20, 2023, 1:00 AM EST - 2 years ago

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Addex Creates Treasury Shares

Dec 14, 2023, 1:00 AM EST - 2 years ago

Addex Creates Treasury Shares

Addex Therapeutics Ltd (ADXN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 1:41 PM EST - 2 years ago

Addex Therapeutics Ltd (ADXN) Q3 2023 Earnings Call Transcript

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Nov 29, 2023, 1:00 AM EST - 2 years ago

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Addex Convenes Extraordinary General Meeting

Nov 28, 2023, 1:00 AM EST - 2 years ago

Addex Convenes Extraordinary General Meeting

NinjaaRai
NinjaaRai Oct. 24 at 8:18 PM
$ADXN $FUSE $QLGN $WGRX
0 · Reply
SpartanVI
SpartanVI Oct. 24 at 8:16 PM
$ADXN $FUSE $QLGN $WGRX Fuse looks ready for ah
0 · Reply
SpartanVI
SpartanVI Oct. 24 at 7:26 PM
$ADXN $FUSE $QLGN $WGRX Fuse Oversold here Potential reversal
0 · Reply
Eliza1
Eliza1 Oct. 24 at 5:00 PM
$ADXN can we just fill the $35 gap already?Another huge one at around $75-$80 when the market was much lower.
0 · Reply
Aaronwasinger
Aaronwasinger Oct. 24 at 8:32 AM
$ADXN $FUSE $QLGN $WGRX
0 · Reply
SpartanVI
SpartanVI Oct. 24 at 8:31 AM
$FUSE '' Charles Cassel hedge manager : predicts 200mil valuation potential // next Q revenue to reveal after it gets uplisted *makes the most sense* // '' $QLGN $ADXN $WGRX
0 · Reply
Manor007
Manor007 Oct. 23 at 8:19 PM
$ADXN load...load...on fire
0 · Reply
Manor007
Manor007 Oct. 23 at 8:11 PM
$ADXN mark my word....
0 · Reply
Manor007
Manor007 Oct. 23 at 8:01 PM
$ADXN going up
1 · Reply
CarlosRivera_
CarlosRivera_ Oct. 21 at 6:49 PM
Took a step back and waited for the right setup. The last one $ADXN hit 15.9 from the alert, can’t say I’m surprised. Got something new on the radar watching it close⚜️
0 · Reply
Eliza1
Eliza1 Oct. 21 at 5:37 PM
$ADXN I agree! Especially with $NERV making a big move today.
0 · Reply
Maryam2000
Maryam2000 Oct. 21 at 4:11 PM
$ADXN 25
0 · Reply
Maryam2000
Maryam2000 Oct. 21 at 2:54 PM
$ADXN
0 · Reply
candlestickmaster
candlestickmaster Oct. 21 at 12:04 PM
$ADXN $DCGO $SGD $ADXN LFG. DYOR.
0 · Reply
Manor007
Manor007 Oct. 20 at 9:32 PM
$ADXN this gonna go up
0 · Reply
CarlosRivera_
CarlosRivera_ Oct. 20 at 6:06 PM
$ADXN Last setup pushed up to 15.9 from the alert. Clean move if you caught it. Watching something new now, it’s starting to look familiar.
1 · Reply
flybyme
flybyme Oct. 20 at 5:41 PM
$ADXN yes quite here and all the new ones have vanished after there pump and dump, be aware and dont get pulled in .It happens here every few months.
0 · Reply
Eliza1
Eliza1 Oct. 20 at 5:33 PM
$ADXN $COMP up 1.5% closing in on its highs-how do you not cover a low float stock like $ADXN and keep shorting? The move 10/17 was on low volume. If this stock gets volume like $RANI and $BYND-THE $75 gap could be filled
0 · Reply
Alflong1
Alflong1 Oct. 20 at 4:55 PM
$ADXN sooo quiet in here
0 · Reply
PRODUCTOF90S
PRODUCTOF90S Oct. 20 at 10:50 AM
$SPY $ADXN If your into trading? Sir this is Stocktwits. We are all into trading! Just dont follow these scammers!
0 · Reply
Unalloyed
Unalloyed Oct. 19 at 7:53 PM
$ADXN https://www.sec.gov/Archives/edgar/data/1574232/000110465924051210/tm2412594-1_424b3.htm
1 · Reply
Maryam2000
Maryam2000 Oct. 19 at 12:43 PM
$ADXN
0 · Reply